US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist

9.4900
+0.0200+0.21%

Close May 17 16:00 ET

9.0800
-0.4100-4.32%

Post 19:30 ET

88.90MMarket Cap-988P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-53.09%-6.17M

8.18%-5.37M

-13.15%-4.58M

-13.29%-18.01M

15.65%-4.1M

-17.74%-4.03M

-74.73%-5.84M

5.45%-4.05M

-23.90%-15.9M

5.86%-4.86M

Net income from continuing operations

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.30%-4.4M

-12.21%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Depreciation and amortization

-3.23%90K

-21.57%80K

-19.61%82K

-2.81%381K

33.33%84K

-18.42%93K

-9.73%102K

0.00%102K

-7.55%392K

-38.24%63K

Change In working capital

-1,185.50%-2.17M

357.46%1.26M

86.09%1.2M

-31.15%714K

1,973.68%356K

143.57%200K

-144.33%-489K

57.04%647K

12,862.50%1.04M

98.75%-19K

-Change in receivables

--0

----

-5,100.00%-50K

--0

----

-96.43%1K

-757.14%-46K

-Change in prepaid assets

151.00%205K

-18.45%137K

222.27%709K

-767.74%-414K

26.87%-400K

---402K

--168K

--220K

1,650.00%62K

---547K

-Change in payables and accrued expense

-446.92%-2.31M

318.93%1.19M

14.93%562K

24.50%1.36M

29.24%747K

205.72%665K

-164.15%-544K

66.89%489K

1,881.82%1.09M

149.87%578K

-Change in other current liabilities

-9.52%-69K

-8.06%-67K

-28.57%-252K

-14.29%-64K

-43.18%-63K

-19.23%-62K

-2.08%-196K

-14.29%-56K

-Change in other working capital

----

-8.75%73K

----

-33.88%80K

-21.21%52K

Cash from discontinued investing activities

Operating cash flow

-53.09%-6.17M

8.18%-5.37M

-13.15%-4.58M

-13.29%-18.01M

15.65%-4.1M

-17.74%-4.03M

-74.73%-5.84M

5.45%-4.05M

-23.90%-15.9M

5.86%-4.86M

Investing cash flow

Cash flow from continuing investing activities

92.31%-1K

-1K

94.12%-13K

Net PPE purchase and sale

----

92.31%-1K

---1K

----

94.12%-13K

----

Cash from discontinued investing activities

Investing cash flow

---179K

--0

92.31%-1K

---1K

--0

94.12%-13K

----

Financing cash flow

Cash flow from continuing financing activities

39K

74.33%27.92M

16.02M

Net common stock issuance

--0

--39K

72.69%30.88M

--17.88M

--0

--17.88M

--0

Net other financing activities

--0

-58.59%-2.96M

---1.87M

--0

---1.87M

----

Cash from discontinued financing activities

Financing cash flow

--0

--39K

74.33%27.92M

--16.02M

--0

--16.02M

--0

Net cash flow

Beginning cash position

93.23%20.39M

56.38%25.88M

-38.91%2.49M

-79.40%4.08M

-23.93%6.57M

-14.52%10.55M

5.12%16.55M

-79.40%4.08M

101.55%19.78M

-28.01%8.63M

Current changes in cash

-57.53%-6.35M

8.85%-5.33M

95.00%23.34M

87.44%-2M

15.86%-4.1M

-17.74%-4.03M

-74.73%-5.84M

379.80%11.97M

-268.04%-15.91M

-163.62%-4.87M

Effect of exchange rate changes

167.44%115K

-6.54%-163K

-91.02%45K

101.96%412K

-92.98%21K

115.52%43K

-183.33%-153K

112.29%501K

-59.12%204K

131.78%299K

End cash Position

115.63%14.16M

93.23%20.39M

56.38%25.88M

-38.91%2.49M

-23.93%6.57M

-14.52%10.55M

5.12%16.55M

-79.40%4.08M

Free cash flow

-57.53%-6.35M

8.18%-5.37M

-13.15%-4.58M

-13.20%-18.01M

15.86%-4.1M

-17.74%-4.03M

-74.73%-5.84M

5.45%-4.05M

-21.90%-15.91M

2.95%-4.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-53.09%-6.17M	8.18%-5.37M	-13.15%-4.58M	-13.29%-18.01M	15.65%-4.1M	-17.74%-4.03M	-74.73%-5.84M	5.45%-4.05M	-23.90%-15.9M	5.86%-4.86M
Net income from continuing operations	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.30%-4.4M	-12.21%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Depreciation and amortization	-3.23%90K	-21.57%80K	-19.61%82K	-2.81%381K	33.33%84K	-18.42%93K	-9.73%102K	0.00%102K	-7.55%392K	-38.24%63K
Change In working capital	-1,185.50%-2.17M	357.46%1.26M	86.09%1.2M	-31.15%714K	1,973.68%356K	143.57%200K	-144.33%-489K	57.04%647K	12,862.50%1.04M	98.75%-19K
-Change in receivables	--0	----	----	-5,100.00%-50K	--0	--0	----	----	-96.43%1K	-757.14%-46K
-Change in prepaid assets	151.00%205K	-18.45%137K	222.27%709K	-767.74%-414K	26.87%-400K	---402K	--168K	--220K	1,650.00%62K	---547K
-Change in payables and accrued expense	-446.92%-2.31M	318.93%1.19M	14.93%562K	24.50%1.36M	29.24%747K	205.72%665K	-164.15%-544K	66.89%489K	1,881.82%1.09M	149.87%578K
-Change in other current liabilities	-9.52%-69K	-9.52%-69K	-8.06%-67K	-28.57%-252K	-14.29%-64K	-43.18%-63K	-43.18%-63K	-19.23%-62K	-2.08%-196K	-14.29%-56K
-Change in other working capital	----	----	----	-8.75%73K	----	----	----	----	-33.88%80K	-21.21%52K
Cash from discontinued investing activities
Operating cash flow	-53.09%-6.17M	8.18%-5.37M	-13.15%-4.58M	-13.29%-18.01M	15.65%-4.1M	-17.74%-4.03M	-74.73%-5.84M	5.45%-4.05M	-23.90%-15.9M	5.86%-4.86M
Investing cash flow
Cash flow from continuing investing activities				92.31%-1K	-1K				94.12%-13K
Net PPE purchase and sale	----	----	----	92.31%-1K	---1K	----	----	----	94.12%-13K	----
Cash from discontinued investing activities
Investing cash flow	---179K	--0	--0	92.31%-1K	---1K	--0	--0	--0	94.12%-13K	----
Financing cash flow
Cash flow from continuing financing activities	0	39K	74.33%27.92M	16.02M	0	0	0	16.02M	0	0
Net common stock issuance	--0	--39K	72.69%30.88M	--17.88M	--0	--0	--0	--17.88M	--0	--0
Net other financing activities	--0	--0	-58.59%-2.96M	---1.87M	--0	--0	--0	---1.87M	----	----
Cash from discontinued financing activities
Financing cash flow	--0	--39K	74.33%27.92M	--16.02M	--0	--0	--0	--16.02M	--0	--0
Net cash flow
Beginning cash position	93.23%20.39M	56.38%25.88M	-38.91%2.49M	-79.40%4.08M	-23.93%6.57M	-14.52%10.55M	5.12%16.55M	-79.40%4.08M	101.55%19.78M	-28.01%8.63M
Current changes in cash	-57.53%-6.35M	8.85%-5.33M	95.00%23.34M	87.44%-2M	15.86%-4.1M	-17.74%-4.03M	-74.73%-5.84M	379.80%11.97M	-268.04%-15.91M	-163.62%-4.87M
Effect of exchange rate changes	167.44%115K	-6.54%-163K	-91.02%45K	101.96%412K	-92.98%21K	115.52%43K	-183.33%-153K	112.29%501K	-59.12%204K	131.78%299K
End cash Position	115.63%14.16M	93.23%20.39M	56.38%25.88M	-38.91%2.49M	-38.91%2.49M	-23.93%6.57M	-14.52%10.55M	5.12%16.55M	-79.40%4.08M	-79.40%4.08M
Free cash flow	-57.53%-6.35M	8.18%-5.37M	-13.15%-4.58M	-13.20%-18.01M	15.86%-4.1M	-17.74%-4.03M	-74.73%-5.84M	5.45%-4.05M	-21.90%-15.91M	2.95%-4.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall